Medicenna Therapeutics Competitors and Similar CompaniesClear all
Medicenna Therapeutics's competitors and similar companies include Salarius Pharmaceuticals, Lyell, AsclepiX Therapeutics and Nkarta Therapeutics.
 Salarius Pharmaceuticals Salarius Pharmaceuticals is a clinical-stage biotechnology company developing epigenetic-based cancer treatments. |  AsclepiX Therapeutics AsclepiX Therapeutics is a biopharmaceutical company which focuses on therapies based on a peptide platform. |  Nkarta Therapeutics Nkarta Therapeutics is a biopharmaceutical company developing engineered natural killer (NK) cell therapies for the treatment of cancer. | |||
Founding Date | Founding Date 2012 | Founding Date 2011 | Founding Date 2018 | Founding Date 2011 | Founding Date 2015 |
Type | Type Public | Type Public | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations HQ | Locations Houston, US HQ | Locations South San Francisco, US HQ Bothell, US Seattle, US | Locations Baltimore, US HQ Jersey City, US | Locations South San Francisco, US HQ |
Employees | Employees 7 | Employees 1225% decrease | Employees 188 | Employees 7 | Employees 1594% decrease |
Valuation ($) | Valuation ($) 122.2 m | Valuation ($) 2.4 m | Valuation ($) 243.3 m | Valuation ($) N/A | Valuation ($) 240.6 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $61k (FY, 2024) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($25.5m) (FY, 2024) | Net income ($5.6m) (FY, 2024) | Net income ($343m) (FY, 2024) | Net income N/A | Net income ($108.8m) (FY, 2024) |
Funding | |||||
Total funding raised | Total funding raised $ 7.5m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 40m | Total funding raised $ 125m |
For sources of this data, please see the company profile
View Company Profiles
Salarius Pharmaceuticals
HQ
Houston, US
Employees
12↓ 25% decrease
Salarius Pharmaceuticals is a clinical-stage biotechnology company developing epigenetic-based cancer treatments.
View company
Lyell
HQ
South San Francisco, US
Employees
188
Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.
View companyAsclepiX Therapeutics
HQ
Baltimore, US
Employees
7
AsclepiX Therapeutics is a biopharmaceutical company which focuses on therapies based on a peptide platform.
View companyNkarta Therapeutics
HQ
South San Francisco, US
Employees
159↓ 4% decrease
Nkarta Therapeutics is a biopharmaceutical company developing engineered natural killer (NK) cell therapies for the treatment of cancer.
View company